Advertisement

Medical Oncology

, Volume 28, Supplement 1, pp 453–461 | Cite as

Antitumor efficacy of a photodynamic therapy-generated dendritic cell glioma vaccine

  • Yuan Shixiang
  • Sun Xi
  • Li Junliang
  • Zhang Shanyi
  • Xu Xingke
  • Zheng Meiguang
  • Wang Kai
  • Li Fangcheng
Original Paper

Abstract

The objective of this study is to generate dendritic cell (DC) vaccines by exposing DCs to C6 glioma cancer cell antigenic (tumor) peptides following the exposure of C6 cells to photodynamic therapy (PDT) and acid elution. Effects of these DCs on host immunity were assessed by measuring cytokine induction (following adaptive transfer into rats) and assessing DC-induced cytotoxic T lymphocyte (CTL)-mediated lysis of C6 target cells. Precursor dendritic cells were purified from rat bone marrow and matured in vitro. C6 cells were stimulated with PDT, and adherent cells were acid-eluted to obtain cell surface antigens, whole cell antigens were also isolated from supernatants. C6 cells not stimulated with PDT were also used to isolate antigens by acid elution or freeze–thaw methods for comparison purposes. The isolated antigens from the respective purification methods were used to sensitize DCs for the generation of DC vaccines subsequently transferred into SD rats. Following adoptive transfer, the changes in interleukin (IL)-12, IL-10, and TNF-α expression were measured in rat serum by ELISA. CTL-mediated lysis was assessed using the MTT assay. PDT-generated antigens further purified by acid elution had the greatest stimulatory effect on DCs based on the elevated serum IL-12 and TNF-α levels and decreased serum IL-10 levels. CTL activity in this group was also highest (percent lysis 95.5% ± 0.016) compared with that elicited by PDT-supernatants, acid elution, and freeze–thawing (or the control group), which had 90.2% ± 0.024, 73.3% ± 0.027, 63.6% ± 0.049, or 0.4% ± 0.063 lysis, respectively. PDT significantly enhanced tumor cell immunogenicity. These data suggested that DC vaccines prepared by treating tumor cells with PDT to generate antigen-specific CTL responses can be developed as novel cancer immunotherapeutic strategies.

Keywords

Photodynamic therapy Acid elution Dendritic cell vaccine Glioma vaccine Cytotoxic T lymphocytes Tumor immunity 

Notes

Acknowledgments

This study was funded by National Natural Science Foundation of China (No. 30770765) and Guangdong Technology Program (No. 2004B31201005).

References

  1. 1.
    Gollnick SO, Liu X, Owczarczak B, Musser DA, Henderson BW. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. J Cancer Res. 1997;57(18):3904–9.Google Scholar
  2. 2.
    Usuda J, Okunaka T, Furukawa K, Tsuchida T, Kuroiwa Y, Ohe Y, Saijo N, Nishio K, Konaka C, Kato H. Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis. J Int J Cancer. 2001;93(4):475–80.CrossRefGoogle Scholar
  3. 3.
    Gollnick SO, Vaughan L, Henderson BW. Generation of effective antitumor vaccines using photodynamic therapy. J Cancer Res. 2002;3(15):1604–8.Google Scholar
  4. 4.
    Korbelik M, Sun J. Photodynamic therapy-generated vaccine for cancer therapy. J Cancer Immunol Immunother. 2006;55(8):900–9.CrossRefGoogle Scholar
  5. 5.
    Jalili A, Makowski M, Switaj T, Nowis D, Wilczynski GM, Wilczek E, Chorazy-Massalska M, Radzikowska A, Maslinski W, Bialy L, Sienko J, Sieron A, Adamek M, Basak G, Mróz P, Krasnodebski IW, Jakóbisiak M, Golab J. Effective photo immunotherapy of murine colon carcinoma induced by the combination of Photodynamic therapy and dendritic cells. J Clin Cancer Res. 2004;10(13):4498–508.CrossRefGoogle Scholar
  6. 6.
    Saji H, Song WR, Furumoto K, Kato H, Engleman EG. Systemic Antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy. J Clin Cancer Res. 2006;12(8):2569–77.Google Scholar
  7. 7.
    Sugawara S, Abo T, Kumagai K. A simple method to eliminate the antigenicity of surface class MHC molecules from the membrane of viable cells by acid treatment at pH3. J Immunol Method. 1987;100(1–2):83–90.CrossRefGoogle Scholar
  8. 8.
    Storkus WJ, Zeh HJ 3rd, Salter RD, Lotze MT. Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. J Immunother Emphasis Tumor Immunol. 1993;14(2):94–103.PubMedCrossRefGoogle Scholar
  9. 9.
    Muthana M, Fairburn B, Mirza S, Slack LK, Pockley AG. Systematic evaluation of the conditions required for the generation of immature rat bone marrow-derived dendritic cells and their phenotypic and functional characterization. J Immunol Methods. 2004;294(1–2):165–79.PubMedCrossRefGoogle Scholar
  10. 10.
    Ohshiro H, Yamaguchi Y, Okabe K, Takai E, Goto M, Zhang JL, Uchino S, Yamada S, Ishihara K, Furuhashi T, Mori K, Ikeda S, Sera Y, Ogawa M. Differential splenic migration of dendritic cells after immunologic unresponsiveness in rat hepatic allografts induced by pretransplant donor-specific transfusion. J Surg Res. 2001;101(1):29–36.PubMedCrossRefGoogle Scholar
  11. 11.
    Wong BR, Josien R, Lee SY, Vologodskaia M, Steinman RM, Choi Y. TRANCE (tumor necrosis factor [TNF] -related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med. 1997;186:2075.PubMedCrossRefGoogle Scholar
  12. 12.
    Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767–811.PubMedCrossRefGoogle Scholar
  13. 13.
    Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1 associated cytokines. J Exp Med. 1996;183(1):87–97.PubMedCrossRefGoogle Scholar
  14. 14.
    Riemensberger J, Bohle A, Brandau S. IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer. J Clin Exp Immunol. 2002;127(1):20–6.CrossRefGoogle Scholar
  15. 15.
    Kawamata A, Ito D, Odani T, Isobe T, Iwase M, Hatori M, Nagumo M. Thalidomide suppresses melanoma growth by activating natural killer cells in mice. J Oncol Rep. 2006;16(6):1231–6.Google Scholar
  16. 16.
    Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K, Liu YC, Karin M. The E3 ubiquitin ligase itch couples JNKactivation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. J Cell. 2006;124(3):601–13.CrossRefGoogle Scholar
  17. 17.
    Ebert LM, Meuter S, Moser B. Homing and function of human skin gamma delta T cells and NK cells: relevance for tumor surveillance. J Immunol. 2006;176(7):4331–6.PubMedGoogle Scholar
  18. 18.
    Ohtani T, Nakamura T, Toda K, Furukawa F. Cyclophosphamide enhanced TNF-alpha-induced apoptotic cell death in murine vascular endothelial cell. J FEBS Lett. 2006;580(6):1597–600.CrossRefGoogle Scholar
  19. 19.
    Yang L, Carbone DP. Tumor-host immune interactions and dendritic cell dysfunction. J Adv Cancer Res. 2004;92(1):13–27.CrossRefGoogle Scholar
  20. 20.
    Yang AS, Lattime EC. Tumor-induced interleukin-10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses. J Cancer Res. 2003;63(9):2150–7.Google Scholar
  21. 21.
    Chen L. Immunological ignorance of silent antigens as an explanation of tumor evasion. J Immunol Today. 1998;19(1):27–30.CrossRefGoogle Scholar
  22. 22.
    Gomer CJ, Luna M, Ferrario A, Wong S, Fisher AM, Rucker N. Cellular targets and molecular responses associated with photodynamic therapy. J Clin LaserMed Surg. 1996;14(5):315–21.Google Scholar
  23. 23.
    Kochevar IE, Lambert CR, Lynch MC, et al. Comparison of photosensitized plasma membrane damage caused by singlet oxygen and free radical. J Biochim Biophys Acta. 1996;1280(2):223–30.CrossRefGoogle Scholar
  24. 24.
    Korbelik M, Sun J, Cecic I. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. J Cancer Res. 2005;65(3):1018–26.Google Scholar
  25. 25.
    Todryk S, Melcher AA, Hardwick N, Linardakis E, Bateman A, Colombo MP, Stoppacciaro A, Vile RG. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J Immunol. 1999;163(3):1398–408.PubMedGoogle Scholar
  26. 26.
    Gollnick SO, Brackett CM. Enhancement of anti-tumor immunity by photodynamic therapy. J Immunol Res. 2010;46(1-3):216–26.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Yuan Shixiang
    • 1
    • 2
  • Sun Xi
    • 3
  • Li Junliang
    • 1
  • Zhang Shanyi
    • 1
  • Xu Xingke
    • 1
  • Zheng Meiguang
    • 1
  • Wang Kai
    • 2
  • Li Fangcheng
    • 1
  1. 1.Department of Neurosurgery, The Second Affiliated HospitalSun Yat-Sen UniversityGuangzhouChina
  2. 2.Department of NeurosurgeryGuangzhou No. 12. hospitalGuangzhouChina
  3. 3.Department of ParasitologyZhongshan Medical College, Sun Yet-Sen UniversityGuangzhouChina

Personalised recommendations